EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY 4.0

Efficacy, Tolerance, and Safety of a Novel Botanical Anti‐Inflammatory Moisturizer in Rosacea: Results From a Double‐Blinded, Randomized Controlled Trial

Zoe Diana Draelos iD

Journal of Cosmetic Dermatology · 2026-05 · 25 (5)

DOI: 10.1111/jocd.70910 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 20.05.2026. Verfasst von Zoe Diana Draelos. Beteiligte Einrichtung: Dermatology Consulting Services, PLCC, High Point, North Carolina, USA. Hauptthemen laut MEDLINE: Rosacea, Anti-Inflammatory Agents, Avena, Aloe. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Crescel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rosacea is characterized by facial erythema that can be resistant to improvement.

Aims

This research evaluated the efficacy and tolerability of a topical anti‐inflammatory moisturizer containing oat and aloe as compared to 0.75% metronidazole cream over 12 weeks.

Methods

This double‐blinded, randomized, controlled trial enrolled 60 adults with mild‐to‐severe rosacea, randomized to either the study anti‐inflammatory moisturizer or 0.75% metronidazole cream daily for 12 weeks. Participants were evaluated at baseline and Weeks 4, 8, and 12. Efficacy was measured by investigator global assessment (IGA) of erythema and inflammatory lesion counts. Tolerability was assessed by the investigator and subjects.

Results

Both study products demonstrated similar IGA scores at Week 4. By Week 8, the study oat and aloe anti‐inflammatory moisturizer demonstrated significantly greater reduction in both erythema IGA (50% vs. 22%, p = 0.001) and lesion counts (74% vs. 6%, p = 0.015). At the conclusion of the 12‐week study, the anti‐inflammatory moisturizer produced a reduction in IGA erythema of 54% vs. 23% ( p < 0.001) and a reduction in inflammatory lesion counts of 74% vs. 17% ( p = 0.044). No tolerability issues were noted.

Conclusions

The oat and aloe anti‐inflammatory moisturizer was superior and outperformed 0.75% metronidazole cream in both erythema and lesion reduction in rosacea subjects after 8 and 12 weeks of treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RosaceaAnti-Inflammatory AgentsAvenaAloePhytotherapyPlant ExtractsHumansDouble-Blind MethodFemaleAdultMetronidazoleMiddle AgedMaleTreatment OutcomeErythemaSkin CreamSeverity of Illness IndexAdministration, CutaneousAged

Stichwörter der Autor:innen

anti‐inflammatorybotanicalfacial erythemarosacea

Substanzen

MetronidazoleAnti-Inflammatory AgentsPlant Extracts

Autor:innen und Institutionen

  • Dermatology Consulting Services, PLCC, High Point, North Carolina, USA.

ORCID-Profile: Zoe Diana Draelos

Förderung

  • Crescel

Zitieren

APA

Draelos, Z. D. (2026). Efficacy, Tolerance, and Safety of a Novel Botanical Anti‐Inflammatory Moisturizer in Rosacea: Results From a Double‐Blinded, Randomized Controlled Trial. Journal of Cosmetic Dermatology, 25(5). https://doi.org/10.1111/jocd.70910

Vancouver

Draelos ZD. Efficacy, Tolerance, and Safety of a Novel Botanical Anti‐Inflammatory Moisturizer in Rosacea: Results From a Double‐Blinded, Randomized Controlled Trial. Journal of Cosmetic Dermatology. 2026;25(5). doi:10.1111/jocd.70910

BibTeX
@article{Draelos2026,
  author = {Draelos, Zoe Diana},
  title = {Efficacy, Tolerance, and Safety of a Novel Botanical Anti‐Inflammatory Moisturizer in Rosacea: Results From a Double‐Blinded, Randomized Controlled Trial},
  journal = {Journal of Cosmetic Dermatology},
  year = {2026},
  volume = {25},
  number = {5},
  doi = {10.1111/jocd.70910}
}
Kostenlos starten →